Skip to main content
Premium Trial:

Request an Annual Quote

HMR Funds Bioinformatics, Cell Research at Harvard


BOSTON--Harvard Medical School has signed a $16 million, five-year research alliance with the pharmaceutical company Hoechst Marion Roussel involving bioinformatics and cell function. Harvard will receive the funding to study common mechanisms of cell function that have potential applications to human disease, including apoptosis, cell-cycle regulation, and cell regeneration.

The alliance takes effect July 1 and stipulates that Hoechst Marion Roussel will have exclusive first rights to negotiate licenses for patents resulting from the research, and can use nonpatented information at no additional cost. Harvard has the right to publish any information resulting from the alliance. Representatives from Hoechst Marion Roussel and Harvard will cochair a steering committee that will review proposals from Medical School faculty and manage fund allocation.

Filed under

The Scan

Gone, But Now Reconstructed SARS-CoV-2 Genomes

In a preprint, a researcher describes his recovery of viral sequences that had been removed from a common database.

Rare Heart Inflammation Warning

The Food and Drug Administration is adding a warning about links between a rare inflammatory heart condition and two SARS-CoV-2 vaccines, Reuters reports.

Sandwich Sampling

The New York Times sent tuna sandwiches for PCR analysis.

Nature Papers Describe Gut Viruses, New Format for Storing Quantitative Genomic Data, More

In Nature this week: catalog of DNA viruses of the human gut microbiome, new dense depth data dump format to store quantitative genomic data, and more.